# BrainChild Bio funding rounds and investors

As of 14 Oct 2026, BrainChild Bio has raised $116M across 1 verified round on record; latest: $116 million Series A, announced 8 Sep 2026.

BrainChild Bio develops CAR T cell therapies focused on treating pediatric and adult brain tumors.

Website: https://brainchildbio.com  
Headquarters: SEATTLE and CAMBRIDGE, Mass.  
Page: https://fireround.dev/companies/brainchildbio.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09-08 | Series A | $116 million | not stated | Seattle Children’s, WRF Capital | [globenewswire.com](https://www.globenewswire.com/news-release/2026/09/08/3357486/0/en/brainchild-bio-closes-116-million-series-a-financing.html) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.